Compound W

Description

Compound W is a salicylic acid-based wart remover formulated for the effective treatment of warts. Each package contains 14 medicated strips designed for topical application. The active ingredient, salicylic acid, is known for its keratolytic properties, facilitating the removal of warts through the exfoliation of the affected skin.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” appearance on the surface, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. For optimal results, the wart may be soaked in warm water for approximately 5 minutes. After soaking, the area must be dried completely.

To apply the medicated pad, the healthcare professional should remove it from the backing paper by pulling from the center of the pad. The pad should then be applied directly to the wart.

This procedure may be repeated every 48 hours as needed, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Application on irritated skin or any area that is infected or reddened is prohibited due to the potential for exacerbating the condition. Additionally, the product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes, as these areas may be sensitive or require specialized treatment.

Furthermore, individuals with diabetes or poor blood circulation should not use this product, as these conditions may increase the risk of adverse effects.

Warnings and Precautions

For external use only. This product is contraindicated for application on irritated skin or any area that is infected or reddened. It should not be used on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, individuals with diabetes or poor blood circulation should refrain from using this product.

In the event that discomfort persists after application, it is advised to discontinue use and consult a healthcare professional for further evaluation.

Immediate medical assistance should be sought if the product is ingested. In such cases, contacting a Poison Control Center at 1-800-222-1222 is recommended for prompt guidance.

Side Effects

Patients should be aware that the product is for external use only. It is contraindicated for use on irritated skin or any area that is infected or reddened. Additionally, the product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes. Patients with diabetes or poor blood circulation should also refrain from using this product.

In the event that discomfort persists, patients are advised to stop use and consult a healthcare professional. It is important to keep the product out of reach of children. If the product is swallowed, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Compound W (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The available data regarding the use of Compound W (salicylic acid) during pregnancy is limited, as the drug insert does not specify any information related to safety concerns, dosage modifications, or special precautions for pregnant patients. Given the lack of comprehensive studies, healthcare professionals should exercise caution when considering the use of this medication in pregnant women.

Due to the absence of established risk categories or known fetal impacts, it is advisable for women of childbearing potential to discuss potential risks and benefits with their healthcare provider before using Compound W during pregnancy.

Lactation

There is no specific information regarding the use of Compound W Maximum Strength One Step Invisible (salicylic acid plaster) in lactating mothers or any lactation considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution and consider the potential risks versus benefits when advising lactating mothers about the use of this product. There are no known data on excretion in breast milk or effects on breastfed infants associated with this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is swallowed, healthcare professionals should be contacted without delay. It is recommended to reach out to a Poison Control Center at 1-800-222-1222 for expert guidance.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should be instructed to seek medical help immediately or contact a Poison Control Center at 1-800-222-1222.

Patients should be cautioned against using the medication on irritated skin or any areas that are infected or reddened. It is important to inform patients that the medication should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes.

Additionally, healthcare providers should emphasize that the medication is not suitable for individuals with diabetes or poor blood circulation. Patients should be advised to discontinue use and consult a doctor if discomfort persists.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at room temperature, ensuring that the temperature does not exceed 37°C (99°F) to maintain product integrity. Care should be taken to avoid exposure to excessive heat during storage and handling.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Compound W, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)